TABLE 1.
Sera from pigs experimentally infected with various CSFV strains
| Serum | Time of testinga | CSFV strain used |
|---|---|---|
| S#1 HC HyperImmune Serum P15-93 (302-08) 94-09-15 | 15 dpc 4 | NA |
| S#2 HC HyperImmune Serum P16-93 94-09-21 | 21 dpc 4 | NA |
| S#3 HC Antiserum P43-83 83-08-16 | 17 dpc 5 | NA |
| S#4 HC Standard Serum P78-82 83-04-18 | 166 dpi | NA |
| S#5 HC P12-93 94-01-12 | 8 dpc | Alfort |
| S#6 HC P17-93 93-12-29 | 56 dpi | Glentorf |
| S#7 HC P18-93 93-12-29 | 56 dpi | Glentorf |
| S#8 HC P19-93 93-12-30 | 57 dpi | Glentorf |
| S#9 HC P4-92 92-06-02 | 7 dpi | Glentorf |
| S#10 HC P4-92 92-06-30 | 35 dpi | Glentorf |
| S#11 HC P5-92 92-06-02 | 7 dpi | Glentorf |
| S#12 HC P5-92 92-06-09 | 14 dpi | Glentorf |
| S#13 HC P5-92 92-06-16 | 21 dpi | Glentorf |
| S#14 HC P5-92 92-06-30 | 35 dpi | Glentorf |
| S#15 HCV HyperImmune Serum P222 64-06-02 | NA | NA |
| S#16 HCV Antiserum L-1 P154 66-06-02 | 210 dpi | Lapinized |
| S#17 HCV Antisera NT P155 66-06-22 | 210 dpc | Lapinized |
| S#18 HCV Immune Sera 51PIC/41 P2427 P3C 69-01-16 | 71 dpi | NA |
| S#19 HCV Antiserum P54-83 83-10-24 | NAb | NA |
| S#20 HC PA03 98-12-14 | 7 dpi | Alfort |
a
Animals tested n dpc were infected with one CSFV strain followed by challenge with other CSFV strains during the course of infection.
b
NA, not available.